Craig-Hallum Downgrades Meridian Biosciences (VIVO) to Hold
Craig-Hallum downgraded Meridian Biosciences (NASDAQ: VIVO) from Buy to Hold with a price target of $22.00 (from $24.00).
For an analyst ratings summary and ratings history on Meridian Biosciences click here. For more ratings news on Meridian Biosciences click here.
Shares of Meridian Biosciences closed at $20.42 yesterday, with a 52 week range of $16.19-$23.05.
For an analyst ratings summary and ratings history on Meridian Biosciences click here. For more ratings news on Meridian Biosciences click here.
Shares of Meridian Biosciences closed at $20.42 yesterday, with a 52 week range of $16.19-$23.05.